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S. ep idmid i s  9142 were isolated, which were completely biofilm 
negative. Linkage of transposon insertions and phenotypic changes 
was proven by phage transduction. Primary attachment of the mu- 
tants to polystyrene was unchanged compared to wildtype, however, 
formation of large cell clusters by the mutants was completely abol- 
ished. The mutants did not produce detectable amounts of the spe- 
cific antigen proving its function in intercellular adhesion of S. epider- 
midis cells essential for b i o f h  accumulation. F'urfication and struc- 
tural analysis of the antigen revealed a polysaccharide mainly com- 
posed of B-1,6-linked 2-amino-2-deoxy-D-glucopyranosid residues. 
80-85% of the sugar residues are N-acetylated whereas the rest 
is non-N-acetylated and positively charged. Due to its function 
we refer to the polysaccharide as polysaccharide intercellular ad- 
hesin (PIA). There was a statistical significant association between 
biohlm-production and PIA expression in 179 clinical S. epidermidis 
isolates. A linear association between the amount of PIA produced as 
detected by ELISA-inhibition and the amount of biofilm produced 
was established for 49 S. epidermidis strains representing a continuum 
h m  biofilm-negative to strongly biofh-producing (r = 0.81, p < 
0,001). Apparently PIA is important for b i o f h  accumulation of the 
majority of clinical S. epidermidis isolates. 
dents suffering b m  staphylococcal infection associated with sta- 
ble orthopedic devices. The patients were assigned to receive ei- 
ther ciprofloxacin/rifampin or ciprofloxacin/placebo. Twenty-four 
patients fully completed the trial. The cure rate was 12/12 in the 
former and 7/12 in the latter group (p = 0.019). Nine patients 
dropped out, mainly due to adverse events. Seven of 9 drop-out pa- 
tients were subsequently treated with rifampin-combinations, partly 
in reduced dose. Six of them were cured, among them 5 patients 
without removal of the device. 
Conclusion: Orthopedic device-related infections due to ri- 
fampin and ciprofloxacin susceptible staphylococci can be cured 
without removal of the device, given the implant is stable, an initial 
dkbridement is performed, and the patient tolerates long-term (3-6 
months) therapy. 
State-of-the-Art Lectures 
I S161 1 Anti-lnfectiie Coatings Can Decrease the Risk of 
Infection Associated with Foreign Bodies 
R. Sherertz. &an Gray School $Medicine, Winston-Salem, NC 
27157, USA 
In the last 20 years there have been increasingly frequent attempts 
to use anti-infective coatings to prevent foreign body infections. 
In animal models (mouse, rat, rabbit) using staphylococci as in- 
fecting organisms efficacious anti-mfective coatings have included 
penicillin G, dicloxach, clindamycin, fusidic acid, chlorhexidine 
(Ch), silver sulfadiazine (AgS), minocycline (M), rifampin (R), and 
benzalkonium chloride as well as certain combinations AgS/Ch, 
M/R, M/EDTA. Ineffective coatings in animal models include 
ciprofloxacin, cefotaxime, Ag and TDMAC. In vivo half-lifes of 
successful coatings range from t 6  h to 2 4  days. In vitm zones of 
inhibition z15 mm by a modhed Kirby-Bauer method have been 
predictive of anti-infective coating efficacy both in animal models 
and in clinical trials. M/R and AgS/Ch coatings have both been 
demonstrated to have efficacy in randomized c h c a l  trials. Ulti- 
mately the optimal coahng must have broad spectrum antimicrobial 
activity and possibly other qualities as well, such as anti-inflammatory 
or anti-thrombotic capabhties. Additional studies are necessary to 
understand the optimal use of anti-mfective coatings and whether 
large scale use will lead to problems with resistance. 
I S162 I Antibiotic Therapy of Staphylococcal 
W. Zimmerli. Division In+ct. Diseases, University Hospitals, Basel, 
Swi t zdand  
Device-related infections persist without treatment and rarely re- 
spond to antimicrobial therapy without removal of the implant. 
This may be due to resistance of adherent bacteria to phagocyto- 
sis and to most antibiotics. A special problem are orthopedic de- 
vice-related infections because these implants cannot easily be re- 
moved. Observational studies showed that despite prolonged (4-6 
weeks) iv-treatment with betalactam antibiotics, the failure rate with 
retention of the device is between 32% and 82%. In contrast, treat- 
ment with quinolone/rifampin combinations showed lower fail- 
ure rates (18-38%) in 2 uncontrolled studies. We therefore con- 
ducted a double blind, randomized clinical trial involving 33 pa- 
Device-Related Infections 
I s163 I Antibiotic Resistance: Quo vadis? 
E Baquero. E 
No abstract available. 
1 S 164 1 Challenges for Future Vaccines 
PH. Lambert. C H  
No abstract available. 
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I S165 I Prevention of HSV transmission: chemotherapy 
or vaccination, what seems approachable 
L. Corcy. University $ Washington G. Fred Hutchinson Cancer Research 
C e n t q  Seattle, WA, USA 
Prevention of HSV transmission is the major scientific question to 
be solved in HSV immunobiology. Tramtionally t h i s  approach has 
best been developed by vaccination. However, several aspects about 
herpes simplex virus lnfection make vaccination a potentially &I- 
cult goal. This includes the very short time between viral inoculation 
on mucosal surfaces and sequestration of the virus within the pro- 
tected site of the neuron. Recent studies with very potent subunit 
vaccines have given less than optimal prevention. Another approach 
to prevention is the use of chemotherapeutic approaches to prevent 
HSV reactivation at mucosal sites. Recent studies have indicated that 
HSV reactivates much more frequently than previously appreciated. 
In immuno-competent persons, HSV DNA is found on mucosal 
surfaces on 25-30% of days. All available data suggest that such HSV 
DNA is infectious and associated with replicating virions in epithe- 
lial cells. These data indicate that a chemotherapeutic approach in 
which daily suppression of viral replication by an antiviral may be 
a useful approach for preventing the transmission of HSV infection. 
This may have important implications with respect to management 
of HSV in pregnancy, the interaction between HSV and HIV in HIV 
infected persons as well as attempting to reduce the transmission of 
HSV between sexual partners. These issues will be discussed. 
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[s1661 Herpes Simplex V i m  Infections of the Nervous 
R. Whitley. U S A  
No abstract available. 
System: Newborns and Adults 
I s167 I Interactions between herpesviluses and HIV 
P.D. GrifKths. Royal Free Hospital School ofMedicine, London, UK 
HIV and herpesviruses may interact in several ways. First, HIV causes 
immunosuppression and pmvides an environment for herpesviruses 
to replicate and cause disease in their own right. Second, reactivated 
herpesviruses may stimulate the replication of HN, accelerating the 
rate at which HIV disease progresses. 
The ways in which herpesviruses can potentially interact with 
HIV can be classded into mechanisms of activating HIV provi- 
ral DNA (hansa&vation, cytokine release, antigen presentation) or 
ways of altering the tropism of HIV (pseudotype formation, CD4 
upregulation, Fe receptor induction).These mechanisms will be de- 
scribed, together with summaries of the clinical studies which have 
been completed to date. Overall, these show that herpesviruses can 
interact with HIV in vivo and that the climcal course of HIV dis- 
ease may be dected adversely. Finally, data fiom controlled aids of 
drugs with anti-herpes activity will be reviewed with the conclusion 
that inhibition of herpesvirus replication is associated with survival 
benefit in HIV-positive patients. 
S168 1 Kaposi's sarcoma: is it a sexually transmitted 
disease? 
P.L. Vernazza. Departmentfor Medicine and Institutefor Clinical 
Microbiology and Immunoloa, St. Gallen, Switzerland 
In the pre-AIDS era, Kaposi's sarcoma (KS) was a rare and mostly 
indolent dermal tumor in elderly men of Mediterranean origin. An 
epidemic form of KS was noted to occur in sub-Saharan Mica. 
In addition, some immunosuppressed renal transplant patient had a 
similar condition. 
The rapidly increasing incidence of KS in HIV infected individuals 
suggested the presence of an underlying condition that would only 
cause disease in the presence of some degree of immunodeficiency. 
The disproportionate high incidence of KS in patients with sexu- 
ally acquired HIV-infection as opposed to other mutes of infection 
prompted some investigators in the mid-e&ties to propose the pres- 
ence of a sexually transmissible pathogen which can lead to KS in 
the presence of cell-mednted immunodeficiency. 
An important step towards the identification of such a sexually 
aansmissible pathogen was the description of the KS-associated Hu- 
man Herpesvirus 8 (HHV-8). Viral sequences of HHV-8 have not 
only been found in KS lesions h m  AIDS patients, but also in KS 
lesions fium HIV negative patients. Serologic tests have confirmed 
the presence of antibodies to this virus in patients with KS> 
After 1983, the incidence of KS in the US declmed rapidly This 
trend was dearly associated with a n  increase of safer sex practices and 
a consequent drop of HIV incidence. The detection of HW-8  in 
some semen samples 6um patients with KS undermines the previous 
epidemiological evidence for a sexually transmissible pathogen. Fu- 
ture studies will have to define the Merent mutes of hansmission of 
HHV-8. 
Overview of opportunistic infections in HIV 
patients 
I S169 I HIV and brain 
P. Portegies. Department ofNmrolqy,  Academic Mediral Centre, 
University of Amsterdam, Amsterdam, "he Netherlands 
News on treatment, primary and secondary p r o p h y b  of Cere- 
bral Tauqplaimosis, and Cryptorocull Meningitis will be discussed. 
Progress in diagnosis, and treatment news for Progressive Mulfttml 
Leukomephnlopathy will be presented. The role of cerebrospinal Buid 
Polymerase Chain &action in the dugnosis of opportunistic infections 
of the nervous system wiU extensively be covered. An update on 
Primary Central Nervous System Lymphoma: diagnosis and aeatment 
will be given. 
HIV dementia will be discussed in detail. HIV dementia largely 
dmppeared fivm the AIDS clinics due to the intmduction of zidovu- 
dine. However, because of intolerance and resistance to zidovudine, 
the disea'se is still there, e s p e d y  in the end-stages of HIV-infection. 
Now that combination treatment has become standarc-treatment 
and people live longer, we do not know what will happen with 
the incidence of HIV-dementia. We do not know how well drugs 
other than zidovudine penetrate into the CNS. and we do not know 
whether these drugs have the capacity to control the HIV brain in- 
fection. AU available CSF-penetration data, and the effects of all the 
antiretroviral drugs on CSF HIV RNA and on HIV-dementia will 
be presented. 
I S170 1 HIV and Lung 
H. Masur. USA 
No abstract available. 
wl HIV and Mucocutaneous Manifestations 
P. Itin. Department Dermatology, University ofBarel, Barel, Switzerland 
Opportunistic mfections cause sigtllficant morbidity and m o d t y  in 
AIDS patients. Cutaneous lesions may give a clue to early dqnosis 
and efficient treatment. The cutaneous and mucosal surfaces are the 
primary barriers against infection and altered barrier function may 
lead infection. The blood supply of the skin can produce metastatic 
spreadfiom and to the skin. HIV-related and associated skin infections 
are characterised by atypical clinical presentation and a protracted 
course. The most common bacterial slan problems an staphylococ- 
cal infections with bullous impetigo, ecthyma, plaque-like folliculitis 
and abscesses. Erythroderma with marked scaling is a W e r  
manifestation. Baclllvy angiomatosis, induced by Bartonella henselae, 
shows violaceous to red nodules imitahng Kaposi's sarcoma. Scabies 
in HN-infected may lead to the crusted nriant, which is highly 
contagious and may produce a n  epidemic by spreading a myriad of 
mites in the exfoliating scales. Opportunistic viral infections include 
cosmetically disfiguring molluscum coneagiosum, human papillo- 
mavirus infections with widespread verrucosis or giant condyloma 
acuminata and carcinoma in situ, severe ulcerating and painful 
herpetic infections, chronic verrucous varicella-zoster infection, 
mucosal CMV infections and EBV-related oral hairy leukoplakia. 
Mycobacterial infections of the skin lead to variable c h c a l  
manifestations including ulcers, subcutaneous abscesses and hyper- 
keratotic plaques. Unusual courses of syphiLs have been reported 
repeatedly Fungal infections include oral candidiasis and superficial 
dermatophyte mfections, htoplasmosis and cryptococcosis. Atypi- 
cal skin changes in AIDS patients should be biopsied and a part of the 
